Blog

Crohn’s Disease is a chronic inflammatory condition of the intestine affecting people of all ages. There is an urgent need for technology to guide the use of powerful and expensive anti-inflammatory medications. Motilent has been awarded  a prestigious UKRI grant to...

British tech company Lifebit and Amazon Web Services to support a dedicated environment for researchers working on COVID-19 vaccines and treatments London, 29 June 2020: Genomics England (GEL) has today launched a next-generation genomic research platform that will...

As the Covid-19 pandemic escalated in March of this year, the scientific community mobilised to support national efforts to understand and contain the virus. At P4 Precision Medicine Accelerator, we brought together academic institutions, private companies and leading...

My Personal Therapeutics (MPT) are thrilled to be moving into their new drug-screening facility in The West Works, White City Place (https://whitecityplace.com). The space is currently being outfitted with a state of the art facility allowing them to ramp up capacity...

We are delighted to announce that Pilar Fernandez Hermida will be joining the P4 Precision Medicine Accelerator. She will be our ad-hoc expert-in-residence in Market Expansion, Partnerships and Business Models. From December, Pilar will mentor start-ups in the P4...

CC Bio, developer of preventative solutions for microbiome dysbiosis, announced today it has been awarded a major grant from Innovate UK, the UK’s innovation agency, to support its ongoing research into the use of bacteriophage derived endolysins for the treatment of...

We are delighted to announce that Laurence Bourn has joined the Motilent team as Chief Technical Officer. Laurence started working with Motilent in August 2019 and will lead the growth of the Company’s technical operations as it enters the clinic. Laurence has 20...

Dr Rayna Patel, Co-Founder & CEO, is a medical doctor & neuroscientist (Cambridge, Harvard, MIT, Columbia). She graduated top of her year from Medicine at Cambridge, and later returned there to complete a GSK-funded MPhil in Translational Medicine (i.e....

Why, Who and When The P4 Precision Medicine Accelerator led by the Institute for Precision Medicine in collaboration with Capital Enterprise was created due to the observations of Professor Phil Beales and Nathan McNally. Phil believes that precision medicine and...